Page last updated: 2024-09-04

schizandrer a and Parkinson Disease

schizandrer a has been researched along with Parkinson Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chong, CM; Guo, BJ; Hoi, PM; Lee, SM; Li, S; Sa, F; Zhang, LQ; Zhang, ZJ; Zheng, Y1
Chen, T; Lee, SM; Li, C; Li, Y; Yi, X; Zheng, Y1

Other Studies

2 other study(ies) available for schizandrer a and Parkinson Disease

ArticleYear
Discovery of novel anti-parkinsonian effect of schisantherin A in in vitro and in vivo.
    Neuroscience letters, 2015, Apr-23, Volume: 593

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Antiparkinson Agents; Brain; Cell Line, Tumor; Cell Survival; Cyclic AMP Response Element-Binding Protein; Cyclooctanes; Dioxoles; Dopaminergic Neurons; Humans; Lignans; Male; Mice, Inbred C57BL; Neuroprotective Agents; Parkinson Disease; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Signal Transduction

2015
Oral Delivery of a Nanocrystal Formulation of Schisantherin A with Improved Bioavailability and Brain Delivery for the Treatment of Parkinson's Disease.
    Molecular pharmaceutics, 2016, 11-07, Volume: 13, Issue:11

    Topics: Administration, Oral; Animals; Brain; Cyclooctanes; Dioxoles; Disease Models, Animal; Drug Compounding; Lignans; Male; Nanoparticles; Parkinson Disease; Rats, Sprague-Dawley; Zebrafish

2016